CBLI

Price

NA


Change

NA


High

NA


Low

NA


Avg Volume

undefined


PE Ratio

NA


52 Week High

NA


52 Week Low

NA



Profile

Cleveland BioLabs, Inc. is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. The company was founded in 2003 and is headquartered in Buffalo, New York. It has license agreements and collaborations with the Cleveland Clinic, Roswell Park Cancer Institute, the Children's Cancer Institute Australia, and the Armed Forces Radiobiology Research Institute. Since 2012, Yakov Cogan has been the CEO of Cleveland BioLabs.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.